News|Videos|October 30, 2026

PharmTech Weekly Roundup—October 30, 2026: Formulation, AI, and NAMs at AAPS PharmSci 360

Author(s)Susan Haigney

The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.

This week on PharmTech.com, coverage from AAPS PharmSci 360 in New Orleans showed that evidence must be trustworthy, whether it comes from an artificial intelligence (AI) model, an organ-on-chip, or a platform formulation. From formulation AI and amorphous solid dispersions (ASDs) to a new FDA framework for gene editing, the common thread was that faster development still depends on data regulators can verify.

Related to this article